Join us:
January 10–12, 2022 in-personJanuary 17–19, 2022 virtually

Stephen Flaim
Senior Special Advisor and Investor-in-Residence at National Institutes of Health


Dr. Flaim holds a doctorate in Human Physiology and Pharmacology from the University of California at Davis. He held faculty positions in Medicine and Physiology at the Pennsylvania State University College of Medicine and senior management roles at the Johnson & Johnson Pharmaceutical Research Institute, the Squibb Institute for Medical Research, Alliance Pharmaceutical Corporation, Trega Biosciences, Inc., Galileo Pharmaceuticals, Inc., OncoFluor, Inc., CardioCreate, Inc. and Leading Biosciences. Dr. Flaim is a Fellow of the American College of Cardiology, the American Heart Association, the American College of Clinical Pharmacology, and emeritus fellow of the Royal Society of Medicine. Dr. Flaim is Chair Emeritus of the Board of Governors for the Tech Coast Angels, Past President and Chair Emeritus of the San Diego Network of Tech Coast Angels and Emeritus Director of the Angel Capital Association. He is a member of the Editorial Board of the Journal of Pharmacology and Experimental Therapeutics, founding member of the Board of Directors, Chairman and CEO of the John G. Watson Foundation and is active in numerous regional and national scientific organizations. He is a Technology and Business advisor to the Institute for the Global Entrepreneur at the University of California, San Diego, and Senior Special Advisor & Investor-in-Residence to the Office of Translational Alliances and Coordination in the Division of Extramural Research Activities at the National Heart, Lung and Blood Institute of the National Institutes of Health.

Agenda Sessions

  • Seed Financing: Value Creation - Laying the foundation to raise money

    On Demand